HK1078793A1 - Aerosol formulation for inhalation comprising a tiotropium salt - Google Patents

Aerosol formulation for inhalation comprising a tiotropium salt

Info

Publication number
HK1078793A1
HK1078793A1 HK05110950A HK05110950A HK1078793A1 HK 1078793 A1 HK1078793 A1 HK 1078793A1 HK 05110950 A HK05110950 A HK 05110950A HK 05110950 A HK05110950 A HK 05110950A HK 1078793 A1 HK1078793 A1 HK 1078793A1
Authority
HK
Hong Kong
Prior art keywords
inhalation
aerosol formulation
tiotropium salt
tiotropium
salt
Prior art date
Application number
HK05110950A
Other languages
English (en)
Inventor
Karin Drechsel
Barbara Niklaus-Humke
Christel Schmelzer
Petra Barth
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28458728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1078793(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of HK1078793A1 publication Critical patent/HK1078793A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53861,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nozzles (AREA)
HK05110950A 2002-04-11 2005-12-01 Aerosol formulation for inhalation comprising a tiotropium salt HK1078793A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10216036A DE10216036A1 (de) 2002-04-11 2002-04-11 Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz
PCT/EP2003/003438 WO2003084519A2 (de) 2002-04-11 2003-04-02 Aerosolformulierung für die inhalation enthaltend ein tiotropiumsalz

Publications (1)

Publication Number Publication Date
HK1078793A1 true HK1078793A1 (en) 2006-03-24

Family

ID=28458728

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05110950A HK1078793A1 (en) 2002-04-11 2005-12-01 Aerosol formulation for inhalation comprising a tiotropium salt

Country Status (33)

Country Link
EP (2) EP1949892A1 (es)
JP (1) JP2005531528A (es)
KR (1) KR100997219B1 (es)
CN (1) CN1309378C (es)
AR (1) AR039286A1 (es)
AT (1) ATE389391T1 (es)
AU (1) AU2003222791B2 (es)
BR (1) BR0309080A (es)
CA (1) CA2473815C (es)
CO (1) CO5611150A2 (es)
CY (1) CY1108133T1 (es)
DE (2) DE10216036A1 (es)
DK (1) DK1496876T3 (es)
EA (1) EA007228B1 (es)
EC (1) ECSP045358A (es)
ES (1) ES2303897T3 (es)
HK (1) HK1078793A1 (es)
HR (1) HRP20040932B1 (es)
ME (1) ME00359B (es)
MX (1) MXPA04009818A (es)
MY (1) MY137249A (es)
NO (1) NO334915B1 (es)
PE (1) PE20030970A1 (es)
PL (1) PL371204A1 (es)
PT (1) PT1496876E (es)
RS (1) RS50923B (es)
SA (1) SA03240192B1 (es)
SI (1) SI1496876T1 (es)
TW (1) TWI344851B (es)
UA (1) UA78994C2 (es)
UY (1) UY27754A1 (es)
WO (1) WO2003084519A2 (es)
ZA (1) ZA200405721B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2067779T1 (sl) 2003-11-03 2013-08-30 Boehringer Ingelheim International Gmbh Tiotropijeve soli, postopek za njihovo pripravo in formulacije zdravil, ki jih vsebujejo
NZ566399A (en) * 2005-08-06 2011-07-29 Boehringer Ingelheim Int Use of tiotropium salts in the treatment of severe persistant asthma
US20070088030A1 (en) 2005-10-10 2007-04-19 Barbara Niklaus-Humke Aerosol formulations for the inhalation of beta-agonists
EP1905440A1 (de) * 2006-09-06 2008-04-02 Boehringer Ingelheim Pharma GmbH & Co. KG Verwendung einer pharmazeutischen Zusammensetzung enthaltend ein Anticholinergikum zur Abtötung von Mikroorganismen und zur Behandlung von Atemwegsinfektionen
EP2044967A1 (de) * 2007-10-01 2009-04-08 Boehringer Ingelheim Pharma GmbH & Co. KG Zerstäuber
WO2013127738A1 (de) 2012-02-28 2013-09-06 Boehringer Ingelheim International Gmbh Neue treibgashaltige tiotropium-formulierung
RU2493827C1 (ru) * 2012-10-03 2013-09-27 Шолекс Девелопмент Гмбх Стабильный комбинированный раствор фенотерола гидробромида и ипратропия бромида
WO2015065223A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Стабильный раствор фенотерола гидробромида
WO2015065219A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Раствор ипратропия бромида
GB201507686D0 (en) * 2015-05-05 2015-06-17 Norton Healthcare Ltd A stable tiotropium nebuliser solution
KR102476726B1 (ko) * 2016-11-16 2022-12-12 글렌마크 스페셜티 에스. 에이. 분무되는 티오트로피움
US20210290568A1 (en) * 2020-03-19 2021-09-23 Cai Gu Huang Inhalable formulation of a solution containing levalbuterol tartrate
CN114259481A (zh) * 2021-11-26 2022-04-01 南京华盖制药有限公司 一种奥达特罗复方吸入溶液

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
IL107120A (en) 1992-09-29 1997-09-30 Boehringer Ingelheim Int Atomising nozzle and filter and spray generating device
DE19536903C2 (de) 1995-10-04 1998-09-10 Boehringer Ingelheim Int Vorrichtung zum Haltern eines fluidischen Bauteils
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19545226C1 (de) 1995-12-05 1997-06-19 Boehringer Ingelheim Int Sperrspannwerk für einen federbetätigten Abtrieb
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
DE19742439C1 (de) 1997-09-26 1998-10-22 Boehringer Ingelheim Int Mikrostrukturiertes Filter
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen
UA78690C2 (uk) * 2000-10-31 2007-04-25 Boehringer Ingelheim Pharma Лікарська композиція для інгаляційного застосування у вигляді розчину із сіллю тіотропію

Also Published As

Publication number Publication date
WO2003084519A3 (de) 2003-12-24
UA78994C2 (uk) 2007-05-10
SA03240192B1 (ar) 2008-01-09
KR100997219B1 (ko) 2010-11-29
DE10216036A1 (de) 2003-10-23
RS87904A (en) 2006-12-15
TW200401653A (en) 2004-02-01
BR0309080A (pt) 2005-02-22
EA007228B1 (ru) 2006-08-25
AU2003222791A1 (en) 2003-10-20
MXPA04009818A (es) 2004-12-13
EP1496876A2 (de) 2005-01-19
ECSP045358A (es) 2004-11-26
MEP54308A (en) 2011-05-10
DE50309414D1 (de) 2008-04-30
DK1496876T3 (da) 2008-06-02
SI1496876T1 (sl) 2008-08-31
CY1108133T1 (el) 2014-02-12
AR039286A1 (es) 2005-02-16
ATE389391T1 (de) 2008-04-15
CN1646108A (zh) 2005-07-27
NO20044001L (no) 2004-10-27
MY137249A (en) 2009-01-30
AU2003222791B2 (en) 2008-09-25
HRP20040932A2 (en) 2005-02-28
NO334915B1 (no) 2014-07-14
HRP20040932B1 (hr) 2013-04-30
EP1949892A1 (de) 2008-07-30
ZA200405721B (en) 2006-05-31
CA2473815A1 (en) 2003-10-16
EA200401305A1 (ru) 2005-06-30
WO2003084519A2 (de) 2003-10-16
CO5611150A2 (es) 2006-02-28
PL371204A1 (en) 2005-06-13
PT1496876E (pt) 2008-04-15
EP1496876B1 (de) 2008-03-19
ME00359B (me) 2011-10-10
UY27754A1 (es) 2003-11-28
CN1309378C (zh) 2007-04-11
CA2473815C (en) 2011-06-14
PE20030970A1 (es) 2004-01-13
TWI344851B (en) 2011-07-11
RS50923B (sr) 2010-08-31
ES2303897T3 (es) 2008-09-01
JP2005531528A (ja) 2005-10-20
KR20040097322A (ko) 2004-11-17

Similar Documents

Publication Publication Date Title
HK1078793A1 (en) Aerosol formulation for inhalation comprising a tiotropium salt
EP1581281A4 (en) INHALATION DEVICE FOR PREPARING A MEDICAMENTAL AEROSOL
IL174496A0 (en) Aerosol formulation for inhalation, containing an anticholinergic agent
EP1581281A3 (en) Inhalation device for producing a drug aerosol
HK1128250A1 (zh) 氣霧型藥物吸入系統
PL376231A1 (en) Powdered medicament for inhalation comprising a tiotropium salt and salmeterol xinafoate
GB0222295D0 (en) Breath actuated medicament dispensing devices
AU2003264253A1 (en) Tiotropium salts for reducing respiratory mortality rate
HK1085918A1 (en) Pulverulent formulation for inhalation containing tiotropium
HK1060569A1 (en) Inhalative solution formulation containing a tiotropium salt
AU2002221741A1 (en) Inhalative solution formulation containing a tiotropium salt
GB2421425B (en) Carrying arrangement for a respiratory protection product
IL155538A0 (en) Inhalative solution formulation containing a tiotropium salt
AU2002221738A1 (en) Inhalative solution formulation containing a tiotropium salt
EP1406592A4 (en) MEDICAL AEROSOL FORMULATION WITH PAIR SALT / ION
GB2402881B (en) A respiratory monitor
AU151319S (en) Aerosol dispenser
GB2406096B (en) A pharmaceutical metered dose aerosol inhaler device
GB0207178D0 (en) A respiratory monitor
GB0210431D0 (en) A respiratory monitor
TW560354U (en) Spraying device for a lawn sprinkler
AU2003901232A0 (en) Dry salt aerosol inhaler
CA94784S (en) Aerosol dispenser
GB0225655D0 (en) Pressurised inhalers

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20230401